Efficacy of IGF-based growth hormone (GH) dosing in nonGH-deficient (nonGHD) short stature children with low IGF-I is not related to basal IGF-I levels

Clinical Endocrinology

Volumn 78, Issue 3, 2013, Pages 405-414

  Cohen, Pinchas ^a   Rogol, Alan D ^b,c   Weng, Wayne ^d   Kappelgaard, Anne Marie ^e   Rosenfeld, Ron G ^f   Germak, John ^d  

^a MATTEL CHILDREN S HOSPITAL   (United States)

^b INDIANA UNIVERSITY   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

^d NOVO NORDISK INC   (United States)

^e NOVO NORDISK A S   (Denmark)

^f OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HUMAN GROWTH HORMONE; INSULIN; RHGH; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ADOLESCENT; ALGORITHM; ARTICLE; BODY HEIGHT; BODY WEIGHT; BONE AGE; CHILD; CHILDHOOD DISEASE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; GLUCOSE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPEN STUDY; PARALLEL DESIGN; PNEUMONIA; PREPUBERTY; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SHORT STATURE; SIDE EFFECT; SUICIDAL IDEATION; TREATMENT DURATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DWARFISM; FEMALE; GROWTH HORMONE; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE;

EID: 84872949012     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12014     Document Type: Article

References (24)

1. Cohen, P., Rogol, A.D., Deal, C.L., et al,. (2008) Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop. Journal of Clinical Endocrinology and Metabolism, 93, 4210-4217. (Pubitemid 352806728)
2. Wit, J.M., Clayton, P.E., Rogol, A.D., et al,. (2008) Idiopathic short stature: definition, epidemiology, and diagnostic evaluation. Growth Hormone & IGF Research, 18, 89-110. (Pubitemid 351292522)
3. ® prescribing information, revised 8/2011. Available online at: http://pi.lilly.com/us/humatrope-cart-pi.pdf (accessed August 2012).
4. ® prescribing information, revised 4/2012. Available online at: http://www.gene.com/gene/products/information/pdf/nutropin- aq-prescribing.pdf (accessed August 2012).
5. ® prescribing information, revised 2/2012. Available online at: http://labeling.pfizer.com/ShowLabeling.aspx?id=577 (accessed August 2012).
6. ® prescribing information, revised 5/2011. Available online at: http://www.novo-pi.com/norditropin.pdf (accessed August 2012).
7. Cohen, P., (2006) Controversy in clinical endocrinology: problems with reclassification of insulin-like growth factor I production and action disorders. Journal of Clinical Endocrinology and Metabolism, 91, 4235-4236. (Pubitemid 44833390)
8. Rosenfeld, R.G., (2005) The molecular basis of idiopathic short stature. Growth Hormone & IGF Research, 15 (Suppl.), 3-5.
9. Rosenfeld, R.G., (2006) Molecular mechanisms of IGF-I deficiency. Hormone Research, 65 (Suppl. 1), 15-20.
10. Lango Allen, H., Estrada, K., Lettre, G., et al,. (2010) Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature, 467, 832-838.
11. Collett-Solberg, P.F., (2011) Update in growth hormone therapy of children. Journal of Clinical Endocrinology and Metabolism, 96, 573-579.
12. Hintz, R.L., Attie, K.M., Baptista, J., et al,. (1999) Effect of growth hormone treatment on adult height of children with idiopathic short stature. Genentech Collaborative Group. New England Journal of Medicine, 340, 502-507. (Pubitemid 29093285)
13. Kamp, G.A., Mul, D., Waelkens, J.J., et al,. (2001) A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation. Journal of Clinical Endocrinology and Metabolism, 86, 2969-2975. (Pubitemid 32673450)
14. Kemp, S.F., Kuntze, J., Attie, K.M., et al,. (2005) Efficacy and safety results of long-term growth hormone treatment of idiopathic short stature. Journal of Clinical Endocrinology and Metabolism, 90, 5247-5253. (Pubitemid 41262282)
15. Leschek, E.W., Rose, S.R., Yanovski, J.A., et al,. (2004) Effect of growth hormone treatment on adult height in peripubertal children with idiopathic short stature: a randomized, double-blind, placebo-controlled trial. Journal of Clinical Endocrinology and Metabolism, 89, 3140-3148. (Pubitemid 38960690)
16. Wit, J.M., Rekers-Mombarg, L.T., Cutler, G.B., et al,. (2005) Growth hormone (GH) treatment to final height in children with idiopathic short stature: evidence for a dose effect. Journal of Pediatrics, 146, 45-53. (Pubitemid 40091730)
17. Wit, J.M., Reiter, E.O., Ross, J.L., et al,. (2008) Idiopathic short stature: management and growth hormone treatment. Growth Hormone & IGF Research, 18, 111-135. (Pubitemid 351292521)
18. Cohen, P., Rogol, A.D., Howard, C.P., et al,. (2007) Insulin growth factor-based dosing of growth hormone therapy in children: a randomized, controlled study. Journal of Clinical Endocrinology and Metabolism, 92, 2480-2486. (Pubitemid 47037346)
19. Cohen, P., Germak, J., Rogol, A.D., et al,. (2010) Variable degree of growth hormone (GH) and insulin-like growth factor (IGF) sensitivity in children with idiopathic short stature compared with GH-deficient patients: evidence from an IGF-based dosing study of short children. Journal of Clinical Endocrinology and Metabolism, 95, 2089-2098.
20. Cohen, P., Bright, G.M., Rogol, A.D., et al,. (2002) Effects of dose and gender on the growth and growth factor response to GH in GH-deficient children: implications for efficacy and safety. Journal of Clinical Endocrinology and Metabolism, 87, 90-98. (Pubitemid 34084676)
21. World Medical Association. (1997) World Medical Association declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. JAMA, 277, 925-926.
22. Mauras, N., Attie, K.M., Reiter, E.O., et al,. (2000) High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group. Journal of Clinical Endocrinology and Metabolism, 85, 3653-3660.
23. Albertsson-Wikland, K., Aronson, A.S., Gustafsson, J., et al,. (2008) Dose-dependent effect of growth hormone on final height in children with short stature without growth hormone deficiency. Journal of Clinical Endocrinology and Metabolism, 93, 4342-4350. (Pubitemid 352789530)
24. Schwarze, C.P., Wollmann, H.A., Binder, G., et al,. (1999) Short-term increments of insulin-like growth factor I (IGF-I) and IGF-binding protein-3 predict the growth response to growth hormone (GH) therapy in GH-sensitive children. Acta Paediatrica, 88 (Suppl. s428), 200-208. (Pubitemid 29108433)